Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Gemma Bonilla"'
Autor:
Iñigo Rúa-Figueroa, David Rúa-Figueroa, Natalia Pérez-Veiga, Ana M. Anzola, María Galindo-Izquierdo, Jaime Calvo-Alén, Antonio Fernández-Nebro, Clara Sangüesa, Raúl Menor-Almagro, Eva Tomero, Natividad del Val, Esther Uriarte-Isazelaya, Ricardo Blanco, José L. Andreu, Alina Boteanu, Javier Narváez, Tatiana Cobo, Cristina Bohórquez, Carlos Montilla, Esteban Salas, Francisco J. Toyos, José A. Bernal, Eva Salgado, Mercedes Freire, Antonio J. Mas, Lorena Expósito, José A. Hernández-Beriain, Oihane Ibarguengoitia, María L. Velloso-Feijoo, Nuria Lozano-Rivas, Gemma Bonilla, Mireia Moreno, Inmaculada Jiménez, Víctor Quevedo-Vila, Angela Pecondón, Elena Aurrecoechea, Elia Valls, Coral Mouriño, Tomás Vázquez-Rodríguez, José M. Pego-Reigosa
Publikováno v:
SEMINARS IN ARTHRITIS AND RHEUMATISM
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO. Repositorio Institucional de Producción Científica
Seminars in Arthritis and Rheumatism
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO. Repositorio Institucional de Producción Científica
Seminars in Arthritis and Rheumatism
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Background/objectives: Factors associated with chronic heart failure (CHF) in patients with systemic lupus erythematosus (SLE) have received little attention. Recent data on the use of hydroxychloroquine in the treatment of SARS-CoV-2 infection have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93365447bb13ae12190dc7e9b94ba685
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8256
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8256
Autor:
José M. Pego-Reigosa, E. Tomero Muriel, E. Uriarte Isacelaya, Elia Valls-Pascual, Elena Aurrecoechea, Iñigo Rúa-Figueroa, I. Jiménez-Moleón, J.A. Narváez, N. Lozano Rivas, Raúl Menor-Almagro, Eduardo Salas, Miriam Moreno, Alina Boteanu, T. R. Vazquez Rodriguez, Lorena Expósito, V. Quevedo Vila, C. A. Montilla-Morales, Antonio Fernández-Nebro, C. Mouriño, Jaime Calvo-Alén, M. Freire González, Gemma Bonilla, J.A. Bernal, Cristina Bohórquez, Tatiana Cobo-Ibáñez, Arantxa Mas, ML Velloso Feijoo, J. A. Hernandez Beriain, Roman Blanco, O. Ibarguengoitia, D. Rua-Figueroa, E. Salgado Perez, J.L. Andreu Sánchez, N. Pérez-Veiga, A. Pecondon, C. Sanguesa, María Galindo-Izquierdo, F. J. Toyos Sáenz de Miera, A. M. Anzola Alfaro, N. Del-Val
Publikováno v:
Annals of the Rheumatic Diseases. 80:610-611
Background:Factors associated with the development of chronic heart failure (CHF) in systemic lupus erythematosus (SLE) have received little attention. On the other hand, recent data from the use of hydroxychloroquine in the treatment of SARS-CoV-2 i
Autor:
Gemma Bonilla, E. Fernández, Irene Monjo, Alejandro Balsa, Chamaida Plasencia, María-Eugenia Miranda-Carús, Eugenio de Miguel
Publikováno v:
Oral Presentations.
Background Giant cell arteritis (GCA) is the most common systemic vasculitis in the elderly. The halo sign has been shown as an accepted valid test in the diagnosis of GCA in trained units1-2. However, to further improve the specificity, the sonograp
Autor:
Trinidad Pérez Sandoval, O. Maiz-Alonso, Mireia López-Corbeto, Clara Aguilera Cros, P. Vela-Casasempere, Ivan Castellví, José Antonio Bernal-Vidal, C. Delgado-Beltran, R. Castellanos-Moreira, Miguel A. González-Gay, Sergi Ordoñez, Alejandra López Robles, J. Loricera, Santos Castañeda, Ricardo Blanco, Iván Cabezas-Rodríguez, A. Juan-Mas, Alejandro Olive, B. Alvarez-Rodríguez, Natalia Mena-Vázquez, A. Urruticoechea-Arana, Maria Lopez Lasanta, José Luis Andréu Sánchez, C. Fito-Manteca, S Rodiguéz-Garcia, A. Ruibal-Escribano, Gemma Bonilla, J.M. Blanco, Raquel Almodóvar, Susana Romero-Yuste, Noelia Alvarez-Rivas, Luis Marcelino Arboleya Rodríguez, Samantha Rodríguez-Muguruza, Mireia Moreno, Francisco Ortiz-Sanjuán, C. Hidalgo, Eva Salgado-Pérez, Ivette Casafont-Solé, C. González-Montagut Gómez, I. Villa-Blanco, Manuel Moreno, J. Fernández-Melon, M. Rodíguez-Gómez, R. López-Sánchez, Deseada Palma Sánchez, Rosa Expósito, I. Hernández-Rodriguez, Carmen Carrasco-Cubero, Patricia Carreira, C. Fernández-Díaz, Blanca Garcia-Magallon, E. C. Cervantes Pérez, C. Ojeda-Garcia, M. Retuerto-Guerrero
Publikováno v:
Abstracts Accepted for Publication.
Background Rheumatoid arthritis (RA) may associate with Interstitial Lung Disease (ILD). Disease-modifying anti-rheumatic drug (DMARD) or TNF alfa inhibitors (iTNF), had been involved in the ILD development as well as exacerbation of an existing one.
Autor:
D. Benavent, C. Tornero, Victoria Navarro-Compán, Alejandro Villalva, María-Eugenia Miranda-Carús, Gemma Bonilla, S. García-Carazo, Laura Nuño, E. Fernández, P. Aguado, Eugenio de Miguel, P. Bogas, Miguel Bernad, Chamaida Plasencia, Alejandro Balsa, Irene Monjo, Diana Peiteado, Ana Castilla
Publikováno v:
Abstracts accepted for Publication.
Background: Nailfold videocapillaroscopy is a non-invasive technique used to assess Raynaud syndrome. It is mainly used for the early diagnosis of connective tissue disorders (CTD) such as systemic sclerosis. There is some evidence that capillaroscop
Autor:
Alejandro Balsa, Chamaida Plasencia, Gemma Bonilla, Eulalia Rodríguez-Martín, Israel Nieto-Gañán, Victoria Navarro-Compán, Mónica Vázquez, Ana Martínez-Feito, Borja Hernández-Breijo, J. Bachiller-Corral, Carlota García-Hoz, Cristina Pijoan Moratalla, Luisa M. Villar, Cristina Sobrino, Paloma Lapuente-Suanzes, Dora Pascual-Salcedo, Garbiñe Roy
Publikováno v:
Abstracts Accepted for Publication.
Background: The most common biological agents used as disease-modifying treatment in rheumatoid arthritis (RA) are TNF inhibitors (TNFi). Although these new strategies to treat RA have improved the course of the disease, approximately 30-50% of patie
Autor:
Paloma Lapuente-Suanzes, Luisa M. Villar, Gemma Bonilla, Borja Hernández-Breijo, Eulalia Rodríguez-Martín, Ana Martínez-Feito, Cristina Sobrino, Israel Nieto-Gañán, Alejandro Balsa, Victoria Navarro-Compán, Chamaida Plasencia, Mónica Vázquez, Carlota García-Hoz, Cristina Pijoan Moratalla, Dora Pascual-Salcedo, Garbiñe Roy, J. Bachiller-Corral
Publikováno v:
Poster Presentations.
Background Rheumatoid arthritis (RA) is a chronic inflammatory disease with the typical characteristic of synovitis of small-sized and medium-sized joints that leads to cartilage and bone damage. TNF inhibitors (TNFi) are widely used for the treatmen
Autor:
Alejandro Villalva, D. Benavent, Victoria Navarro-Compán, Diana Peiteado, Chamaida Plasencia, Gemma Bonilla, Alejandro Balsa, E. Fernández
Publikováno v:
Abstracts accepted for Publication.
Background Gender has been lately suggested as influential in the response to treatment with biological drugs in spondyloarthritis, such as psoriatic arthritis (PsA). However, data about the association between gender and treatment response in axial
Autor:
Gemma Bonilla, L. Lojo Oliveira, O. Sanchez Pernaute, A. García Fernández, J. Bachiller-Corral, C. Bonilla Gonzalez-Leganá, S. Perez Esteban, M. Pavia Pascual, Laura Nuño, S. Recuero Diaz, J. J. Sanmartin Martinez, N. De La Torre, D. Clemente Garulo, J. M. Rodríguez Herredia, Alina Boteanu
Publikováno v:
Annals of the Rheumatic Diseases. 80:914-914
Background:Patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 may be at risk to develop a severe course of COVID-19 due to the immune dysregulation or the influence of immunomodulating drugs on the course of the infection. F
Autor:
Luisa M. Villar, Cristina Sobrino, Gemma Bonilla, Dora Pascual-Salcedo, Eulalia Rodríguez-Martín, Borja Hernández-Breijo, Paloma Lapuente-Suanzes, Ana Martínez-Feito, Victoria Navarro-Compán, Chamaida Plasencia, Carlota García-Hoz, Israel Nieto-Gañán, C. Pijoan-Moratalla, J. Bachiller-Corral, Alejandro Balsa, Mónica Vázquez
Publikováno v:
Annals of the Rheumatic Diseases. 80:549.2-550
Background:In clinical practice no more than 50% of the patients treated with TNF inhibitors (TNFi) achieve remission (REM). Previous investigations suggested that peripheral blood mononuclear cells (PBMC) may be markers associated with the TNFi trea